VitalHub Reports Fourth Quarter and Annual 2024 Results

Core Insights - VitalHub Corp. reported a significant increase in Annual Recurring Revenue (ARR), which rose by 59% year-over-year to $71.1 million [1][6][9] - Total revenue for the year increased by 51% year-over-year, reaching $20.6 million [1][7] - Adjusted EBITDA grew by 27% year-over-year to $5.0 million, reflecting a strong operational performance [1][9] Financial Performance - The company achieved organic ARR growth of 15% and acquisition ARR growth of 40% for the year [3][6] - In Q4 2024, the company reported a sequential net new organic ARR of $2.6 million, with balanced contributions from its EHR suite in Canada and patient flow solutions in the UK [3] - Total revenue for 2024 was $68.6 million, an increase of 31% compared to the previous year [6][7] Acquisitions and Growth Strategy - VitalHub completed four acquisitions in 2024, contributing an additional $17.9 million in ARR [3][6] - The company is focused on integrating new solutions and enhancing operational efficiency post-acquisition [3] - VitalHub's pro forma cash balance is approximately $90 million, indicating strong cash generation and readiness for further M&A activities [3][8] Operational Metrics - Gross profit margin remained strong at 81%, although it slightly decreased from 83% in the prior year [6][7] - The company reported a net income before income taxes of $5.9 million, an increase of 11% year-over-year [6][9] - Adjusted EBITDA as a percentage of revenue was 26%, compared to 25% in the prior year, indicating improved profitability [8][9] Market Position and Future Outlook - VitalHub serves over 1,000 clients globally, with a robust product suite aimed at health and human services providers [10] - The company is positioned for sustained growth through both organic opportunities and an aggressive M&A strategy [10] - VitalHub's quarterly investor conference call is scheduled for March 28, 2025, to discuss further developments [3][4]